clioquinol has been researched along with ciclopirox in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Burrows, LL; Chan, DCK; Guo, I | 1 |
Andrade, SF; Andrzejewski Kaminski, TF; da Costa, B; Fuentefria, AM; Pippi, B | 1 |
de Andrade, SF; de Chaves, MA; Fernanda Andrzejewski Kaminski, T; Ferreira do Amaral, T; Flavio Souza de Oliveira, L; Fuentefria, AM; Monteiro da Silva Rodrigues Coutinho, N; Teixeira, ML | 1 |
Andrade, SF; Berlitz, SJ; Carvalho, AR; da Costa, B; Fuentefria, AM; Külkamp-Guerreiro, IC; Pippi, B; Teixeira, ML | 1 |
5 other study(ies) available for clioquinol and ciclopirox
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Forging New Antibiotic Combinations under Iron-Limiting Conditions.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ciclopirox; Clioquinol; Doxycycline; Gallium; Iron; Iron Deficiencies; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tropolone | 2020 |
In vitro antidermatophytic synergism of double and triple combination of clioquinol with ciclopirox and terbinafine.
Topics: Antifungal Agents; Arthrodermataceae; Cell Survival; Ciclopirox; Clioquinol; Drug Combinations; Drug Synergism; Fungi; Humans; Leukocytes; Microbial Sensitivity Tests; Terbinafine; Tinea | 2020 |
Synergistic association of clioquinol with antifungal drugs against biofilm forms of clinical Fusarium isolates.
Topics: Antifungal Agents; Biofilms; Ciclopirox; Clioquinol; Drug Combinations; Drug Synergism; Fusariosis; Fusarium; Humans; Leukocytes; Microbial Sensitivity Tests; Voriconazole | 2020 |
Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.
Topics: Animals; Antifungal Agents; Ciclopirox; Clioquinol; Dermatomycoses; Disease Models, Animal; Drug Combinations; Humans; Microbial Sensitivity Tests; Swine; Terbinafine | 2021 |